Alzheon's Alzheimer's drug knocked down in pivotal APOLLOE4 bout
Alzheon’s attempt to rescue a once-failed idea for treating Alzheimer’s disease has flopped. Sixteen years after tramiprosate flunked a phase 3 trial, Alzheon’s prodrug form of the molecule has joined the lengthy list of pivotal Alzheimer’s failures.
Alzheon’s attempt to rescue a once-failed idea for treating Alzheimer’s disease has flopped. Sixteen years after tramiprosate flunked a phase 3 trial, Alzheon’s prodrug form of the molecule has joined the lengthy list of pivotal Alzheimer’s failures.
